Jencia Wong
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Jencia Wong has a total of 90 co-authors. Here are the top co-authors by number of shared publications:
Amanda Gauld
Department of Endocrinology Royal Prince Alfred Hospital Sydney New South Wales Australia
4 shared publications- Maria Constantino
Diabetes Centre, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia
4 shared publications - Timothy L. Middleton
Diabetes Centre, Royal Prince Alfred Hospital, Level 6 West, 50 Missenden Road, Sydney, NSW, 2050, Australia, 61 295155888, 61 295155820
4 shared publications - Margaret McGill
Diabetes Centre, Royal Prince Alfred Hospital, Level 6 West, 50 Missenden Road, Sydney, NSW, 2050, Australia, 61 295155888, 61 295155820
3 shared publications - Stephen Morris Twigg
Greg Brown Diabetes and Endocrine Research Laboratory, Sydney Medical School (Central), Faculty of Medicine and Health, Charles Perkins Centre, The University of Sydney, Sydney, NSW 2006, Australia
3 shared publications - Ted Wu
Diabetes Centre, Royal Prince Alfred Hospital, Level 6 West, 50 Missenden Road, Sydney, NSW, 2050, Australia, 61 295155888, 61 295155820
3 shared publications
Latest Publications
- Open Access
- 8 August 2025
- Published by JMIR Publications Inc. in JMIR Diabetes
- Vol. 10, e68214
A Nurse-Led Telemonitoring Approach in Diabetes During the COVID-19 Pandemic: Prospective Cohort Study
Background: The utility of a nurse-led telemonitoring approach (NLTA) is yet to be firmly established in diabetes management. Objective: This study aims to examine the effect of a 12-month proactive NLTA on metabolic and psychological health indices in individuals with diabetes during the COVID-19 pandemic, and to evaluate it as a new diabetes model of care. Methods: The telemonitoring study group (TSG; n=91) comprised adults who had attended an Australian tertiary hospital diabetes center between January 2019 and March 2020. Telehealth surveillance contact with a diabetes nurse educator was subsequently maintained at approximately 3-month intervals over 12 months. Prospective surveillance measures included glycated hemoglobin A1c (HbA1c%), weight, adherence to healthy behaviors, and patient-reported outcomes of diabetes distress, anxiety, and depression using validated instruments. Metabolic changes were compared retrospectively with a comparison group who had not received telemonitoring contact during the study period (non-TSG; n=115). Results: The average participant age was 57.2 (SD 15) years; 63% (129/206) were male, 48% (99/206) had type 1 diabetes, 50% (104/206) had type 2 diabetes, and the mean HbA1c% was 8.1% (SD 1.4%). At the end of the 12-month study, the relative percentage reduction in unadjusted HbA1c% for the TSG cohort was significantly greater than that observed in the non-TSG cohort (4% vs 1%; P=.04). Following adjustment for baseline HbA1c%, a significant improvement in HbA1c% was observed in the TSG (P=.048) but not in the non-TSG (P=.61). TSG participants were 40% less likely (odds ratio 0.6, 95% CI 0.5‐0.7) to experience an unfavorable rise in HbA1c% compared to non-TSG participants, after adjusting for sex, age, prepandemic HbA1c%, ethnicity, diabetes type, and diabetes duration. The NLTA facilitated assessments of psychological risk, with elevated depression, anxiety and diabetes distress scores significantly increased in women and youth P<.001). Increasing anxiety measures were observed in those with high baseline anxiety scores (P<.001). Conclusions: A proactive diabetes NLTA is feasible with positive effects on glycemia and the potential to identify those at psychological risk for targeted intervention. In the context of increasing demand for diabetes-related resources, further study of an NLTA model of care is warranted.
- 8 August 2025
- Published by JMIR Publications Inc. in JMIR Diabetes
- Vol. 10, e68214
Open AccessA Nurse-Led Telemonitoring Approach in Diabetes During the COVID-19 Pandemic: Prospective Cohort Study
Background: The utility of a nurse-led telemonitoring approach (NLTA) is yet to be firmly established in diabetes management. Objective: This study aims to examine the effect of a 12-month proactive NLTA on metabolic and psychological health indices in individuals with diabetes during the COVID-19 pandemic, and to evaluate it as a new diabetes model of care. Methods: The telemonitoring study group (TSG; n=91) comprised adults who had attended an Australian tertiary hospital diabetes center between January 2019 and March 2020. Telehealth surveillance contact with a diabetes nurse educator was subsequently maintained at approximately 3-month intervals over 12 months. Prospective surveillance measures included glycated hemoglobin A1c (HbA1c%), weight, adherence to healthy behaviors, and patient-reported outcomes of diabetes distress, anxiety, and depression using validated instruments. Metabolic changes were compared retrospectively with a comparison group who had not received telemonitoring contact during the study period (non-TSG; n=115). Results: The average participant age was 57.2 (SD 15) years; 63% (129/206) were male, 48% (99/206) had type 1 diabetes, 50% (104/206) had type 2 diabetes, and the mean HbA1c% was 8.1% (SD 1.4%). At the end of the 12-month study, the relative percentage reduction in unadjusted HbA1c% for the TSG cohort was significantly greater than that observed in the non-TSG cohort (4% vs 1%; P=.04). Following adjustment for baseline HbA1c%, a significant improvement in HbA1c% was observed in the TSG (P=.048) but not in the non-TSG (P=.61). TSG participants were 40% less likely (odds ratio 0.6, 95% CI 0.5‐0.7) to experience an unfavorable rise in HbA1c% compared to non-TSG participants, after adjusting for sex, age, prepandemic HbA1c%, ethnicity, diabetes type, and diabetes duration. The NLTA facilitated assessments of psychological risk, with elevated depression, anxiety and diabetes distress scores significantly increased in women and youth P<.001). Increasing anxiety measures were observed in those with high baseline anxiety scores (P<.001). Conclusions: A proactive diabetes NLTA is feasible with positive effects on glycemia and the potential to identify those at psychological risk for targeted intervention. In the context of increasing demand for diabetes-related resources, further study of an NLTA model of care is warranted.
- Open Access
- 22 May 2025
- Published by Wiley in Diabetic Medicine
- Vol. 42 (8) , e70049
Pregnancy outcomes in women with young‐onset type 2 diabetes: the impact of age of diabetes diagnosis and duration of diabetes
Aims: Young‐onset type 2 diabetes mellitus (YT2DM) is an aggressive phenotype, with some claiming that diagnosis at N = 69), T2D30 ( N = 66) were significantly younger, had a longer duration of diabetes, and had higher rates of smoking ( p p <0.05 for both). Conclusions: An earlier age of YT2DM diagnosis and/or longer duration of YT2DM were associated with excess GWG and a higher mean‐pregnancy HbA1c. Rates of pre‐eclampsia and proteinuria were increased in T2D30, likely mediated at least in part by factors such as glycaemia. Our findings suggest that the age of YT2DM diagnosis and/or duration of YT2DM, not just maternal age, should be considered when assessing pregnancy risks.
- 22 May 2025
- Published by Wiley in Diabetic Medicine
- Vol. 42 (8) , e70049
Open AccessPregnancy outcomes in women with young‐onset type 2 diabetes: the impact of age of diabetes diagnosis and duration of diabetes
Aims: Young‐onset type 2 diabetes mellitus (YT2DM) is an aggressive phenotype, with some claiming that diagnosis at N = 69), T2D30 ( N = 66) were significantly younger, had a longer duration of diabetes, and had higher rates of smoking ( p p <0.05 for both). Conclusions: An earlier age of YT2DM diagnosis and/or longer duration of YT2DM were associated with excess GWG and a higher mean‐pregnancy HbA1c. Rates of pre‐eclampsia and proteinuria were increased in T2D30, likely mediated at least in part by factors such as glycaemia. Our findings suggest that the age of YT2DM diagnosis and/or duration of YT2DM, not just maternal age, should be considered when assessing pregnancy risks.
- 1 February 2022
- Published by Bentham Science Publishers Ltd. in Current Diabetes Reviews
- Vol. 18 (2) , 1
Physicians’ Perception About Use of Vitamin B12 in the Treatment or Prevention of Diabetic Neuropathy: A Cross-sectional Survey in Saudi Arabia
Background: Diabetic neuropathy is a condition that is prevalent among type 2 diabetic patients. Some physicians prescribe vitamin B12 or vitamin B complex supplements to improve symptoms, but studies have shown that there is little to no evidence of vitamin B12 being an effective treatment for diabetic neuropathy. Thus, this study aims to investigate local physicians’ knowledge and tendency to prescribe vitamin B12 or vitamin B complex for the treatment or prevention of diabetic peripheral neuropathy.Methods: It was a cross-sectional study, conducted between May and November of 2019, in several primary healthcare centers in different cities of Saudi Arabia. A total of 412 physicians with a minimum of three years of experience answered a three-part questionnaire on their demographic information, their prescribing behavior, and their knowledge of the relationship between vitamin B12 or vitamin B complex and diabetic neuropathy.Results: The study found that only 42% of the physicians believed that vitamin B12 supplementation did not prevent diabetic neuropathy, while only 52.7% found it to be an ineffective treatment for this condition. Moreover, 58.7% stated that they had indeed prescribed vitamin B12 or multivitamins as a form of treatment or prevention of diabetic neuropathy. 47.8% of the patients requested a vitamin B12 prescription 1-6 times from their physicians, while 31.6% of them requested it ≥ 7 times, with 42.5% of physicians agreeing that their prescriptions of vitamin B12 had been a result of patient demand more than clinical justification. Likewise, 43% of respondents were aware that vitamin B12 levels should be tested annually. Furthermore, a higher proportion of consultants chose not to prescribe vitamin B12 to prevent or treat diabetic neuropathy than any other rank.Conclusion: The findings of this study indicate a tendency of unnecessarily prescribing vitamin B12 supplementation for the prevention or treatment of diabetic neuropathy as well as a lack of knowledge on the matter among doctors in primary care hospitals in Saudi Arabia. The study has also shown that it is patients who often request this prescription, adding pressure on their physicians to comply. Future studies should investigate hospitals in a greater number of Saudi cities and include less experienced residents and medical students.
- 1 February 2022
- Published by Bentham Science Publishers Ltd. in Current Diabetes Reviews
- Vol. 18 (2) , 1
Physicians’ Perception About Use of Vitamin B12 in the Treatment or Prevention of Diabetic Neuropathy: A Cross-sectional Survey in Saudi Arabia
Background: Diabetic neuropathy is a condition that is prevalent among type 2 diabetic patients. Some physicians prescribe vitamin B12 or vitamin B complex supplements to improve symptoms, but studies have shown that there is little to no evidence of vitamin B12 being an effective treatment for diabetic neuropathy. Thus, this study aims to investigate local physicians’ knowledge and tendency to prescribe vitamin B12 or vitamin B complex for the treatment or prevention of diabetic peripheral neuropathy.Methods: It was a cross-sectional study, conducted between May and November of 2019, in several primary healthcare centers in different cities of Saudi Arabia. A total of 412 physicians with a minimum of three years of experience answered a three-part questionnaire on their demographic information, their prescribing behavior, and their knowledge of the relationship between vitamin B12 or vitamin B complex and diabetic neuropathy.Results: The study found that only 42% of the physicians believed that vitamin B12 supplementation did not prevent diabetic neuropathy, while only 52.7% found it to be an ineffective treatment for this condition. Moreover, 58.7% stated that they had indeed prescribed vitamin B12 or multivitamins as a form of treatment or prevention of diabetic neuropathy. 47.8% of the patients requested a vitamin B12 prescription 1-6 times from their physicians, while 31.6% of them requested it ≥ 7 times, with 42.5% of physicians agreeing that their prescriptions of vitamin B12 had been a result of patient demand more than clinical justification. Likewise, 43% of respondents were aware that vitamin B12 levels should be tested annually. Furthermore, a higher proportion of consultants chose not to prescribe vitamin B12 to prevent or treat diabetic neuropathy than any other rank.Conclusion: The findings of this study indicate a tendency of unnecessarily prescribing vitamin B12 supplementation for the prevention or treatment of diabetic neuropathy as well as a lack of knowledge on the matter among doctors in primary care hospitals in Saudi Arabia. The study has also shown that it is patients who often request this prescription, adding pressure on their physicians to comply. Future studies should investigate hospitals in a greater number of Saudi cities and include less experienced residents and medical students.
- Open Access
- 21 October 2021
- Published by JMIR Publications Inc. in Journal of Medical Internet Research
- Vol. 23 (10) , e27263
An Enhanced SMS Text Message–Based Support and Reminder Program for Young Adults With Type 2 Diabetes (TEXT2U): Randomized Controlled Trial
Background: Clinic attendance, metabolic control, engagement in self-management, and psychological health are suboptimal in young-onset (age of onset 90% of participants would recommend the program to new patients. Conclusions: An enhanced SMS text message–based support and reminder program doubled scheduled clinic attendance rates for patients with young-onset type 2 diabetes. The program was highly acceptable and provided early support for patient empowerment but had no significant effect on measures of metabolic control or self-management. Trial Registration: Australian and New Zealand Clinical Trials Registry (ACTRN12618000479202); https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=373579
- 21 October 2021
- Published by JMIR Publications Inc. in Journal of Medical Internet Research
- Vol. 23 (10) , e27263
Open AccessAn Enhanced SMS Text Message–Based Support and Reminder Program for Young Adults With Type 2 Diabetes (TEXT2U): Randomized Controlled Trial
Background: Clinic attendance, metabolic control, engagement in self-management, and psychological health are suboptimal in young-onset (age of onset 90% of participants would recommend the program to new patients. Conclusions: An enhanced SMS text message–based support and reminder program doubled scheduled clinic attendance rates for patients with young-onset type 2 diabetes. The program was highly acceptable and provided early support for patient empowerment but had no significant effect on measures of metabolic control or self-management. Trial Registration: Australian and New Zealand Clinical Trials Registry (ACTRN12618000479202); https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=373579
- Open Access
- 19 January 2021
- Published by JMIR Publications Inc. in JMIR Preprints
An Enhanced SMS Text Message–Based Support and Reminder Program for Young Adults With Type 2 Diabetes (TEXT2U): Randomized Controlled Trial (Preprint)
BACKGROUND Clinic attendance, metabolic control, engagement in self-management, and psychological health are suboptimal in young-onset (age of onset 90% of participants would recommend the program to new patients. CONCLUSIONS An enhanced SMS text message–based support and reminder program doubled scheduled clinic attendance rates for patients with young-onset type 2 diabetes. The program was highly acceptable and provided early support for patient empowerment but had no significant effect on measures of metabolic control or self-management. CLINICALTRIAL Australian and New Zealand Clinical Trials Registry (ACTRN12618000479202); https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=373579
- 19 January 2021
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessAn Enhanced SMS Text Message–Based Support and Reminder Program for Young Adults With Type 2 Diabetes (TEXT2U): Randomized Controlled Trial (Preprint)
BACKGROUND Clinic attendance, metabolic control, engagement in self-management, and psychological health are suboptimal in young-onset (age of onset 90% of participants would recommend the program to new patients. CONCLUSIONS An enhanced SMS text message–based support and reminder program doubled scheduled clinic attendance rates for patients with young-onset type 2 diabetes. The program was highly acceptable and provided early support for patient empowerment but had no significant effect on measures of metabolic control or self-management. CLINICALTRIAL Australian and New Zealand Clinical Trials Registry (ACTRN12618000479202); https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=373579
- Top Cited PapersOpen Access
- 14 December 2020
- Published by Springer Nature in Diabetologia
- Vol. 64 (2) , 275-287
Impact of age at type 2 diabetes mellitus diagnosis on mortality and vascular complications: systematic review and meta-analyses
Aims/hypothesis: Few studies examine the association between age at diagnosis and subsequent complications from type 2 diabetes. This paper aims to summarise the risk of mortality, macrovascular complications and microvascular complications associated with age at diagnosis of type 2 diabetes. Methods: Data were sourced from MEDLINE and All EBM (Evidence Based Medicine) databases from inception to July 2018. Observational studies, investigating the effect of age at diabetes diagnosis on macrovascular and microvascular diabetes complications in adults with type 2 diabetes were selected according to pre-specified criteria. Two investigators independently extracted data and evaluated all studies. If data were not reported in a comparable format, data were obtained from authors, presented as minimally adjusted ORs (and 95% CIs) per 1 year increase in age at diabetes diagnosis, adjusted for current age for each outcome of interest. The study protocol was recorded with PROSPERO International Prospective Register of Systematic Reviews (CRD42016043593). Results: Data from 26 observational studies comprising 1,325,493 individuals from 30 countries were included. Random-effects meta-analyses with inverse variance weighting were used to obtain the pooled ORs. Age at diabetes diagnosis was inversely associated with risk of all-cause mortality and macrovascular and microvascular disease (all p < 0.001). Each 1 year increase in age at diabetes diagnosis was associated with a 4%, 3% and 5% decreased risk of all-cause mortality, macrovascular disease and microvascular disease, respectively, adjusted for current age. The effects were consistent for the individual components of the composite outcomes (all p < 0.001). Conclusions/interpretation: Younger, rather than older, age at diabetes diagnosis was associated with higher risk of mortality and vascular disease. Early and sustained interventions to delay type 2 diabetes onset and improve blood glucose levels and cardiovascular risk profiles of those already diagnosed are essential to reduce morbidity and mortality.
- 14 December 2020
- Published by Springer Nature in Diabetologia
- Vol. 64 (2) , 275-287
Top Cited PapersOpen AccessImpact of age at type 2 diabetes mellitus diagnosis on mortality and vascular complications: systematic review and meta-analyses
Aims/hypothesis: Few studies examine the association between age at diagnosis and subsequent complications from type 2 diabetes. This paper aims to summarise the risk of mortality, macrovascular complications and microvascular complications associated with age at diagnosis of type 2 diabetes. Methods: Data were sourced from MEDLINE and All EBM (Evidence Based Medicine) databases from inception to July 2018. Observational studies, investigating the effect of age at diabetes diagnosis on macrovascular and microvascular diabetes complications in adults with type 2 diabetes were selected according to pre-specified criteria. Two investigators independently extracted data and evaluated all studies. If data were not reported in a comparable format, data were obtained from authors, presented as minimally adjusted ORs (and 95% CIs) per 1 year increase in age at diabetes diagnosis, adjusted for current age for each outcome of interest. The study protocol was recorded with PROSPERO International Prospective Register of Systematic Reviews (CRD42016043593). Results: Data from 26 observational studies comprising 1,325,493 individuals from 30 countries were included. Random-effects meta-analyses with inverse variance weighting were used to obtain the pooled ORs. Age at diabetes diagnosis was inversely associated with risk of all-cause mortality and macrovascular and microvascular disease (all p < 0.001). Each 1 year increase in age at diabetes diagnosis was associated with a 4%, 3% and 5% decreased risk of all-cause mortality, macrovascular disease and microvascular disease, respectively, adjusted for current age. The effects were consistent for the individual components of the composite outcomes (all p < 0.001). Conclusions/interpretation: Younger, rather than older, age at diabetes diagnosis was associated with higher risk of mortality and vascular disease. Early and sustained interventions to delay type 2 diabetes onset and improve blood glucose levels and cardiovascular risk profiles of those already diagnosed are essential to reduce morbidity and mortality.
- 1 June 2020
- Published by American Diabetes Association in Diabetes
- Vol. 69 (Supplement)
1236-P: Perceptions of People with Early-Onset Type 2 Diabetes Mellitus about Diabetes and Exercise
Background: The prevalence of early-onset type 2 diabetes (EOT2D, diagnosed with T2DM under the age 40) is increasing. There is limited research on the perceptions and knowledge about diabetes and its management. The aim of the study was to explore the insights on diabetes and exercise among this cohort. Method: Twelve participants who underwent an 8-week, supervised, high-intensity intermittent training (HIIT) program were invited to participate in a semi-structured interview. The interview explored exercise history, perception of EOT2D, knowledge of EOT2D management and complications, feedback on HIIT, and barriers and facilitators to regular exercise. Inductive thematic analysis was used. Results: Eight males and four females aged between 20-44 years were interviewed. Four themes emerged from analysis: (i) The diagnosis of T2DM was often unexpected. Participants reported the sense of “loss control” at diagnosis. This motivated people to exercise, but regular and structured exercise was rarely maintained: “didn’t continue after a few months.” (ii) Participants had varying levels of knowledge about diabetes, its management and complications: “⋯didn’t really understand how T2DM works and how exercise could affect it.” Most participants did not monitor blood glucose levels regularly: “monitoring sugar regularly to me is obsessive behaviour.” (iii) Financial and time commitments were the two most common barriers to exercise, especially for people with young children. (iv) HIIT was well-tolerated. Participants valued the individual supervision - “having the supervision gives you structure and a commitment.” However, participants were unlikely to continue with the HIIT program independently or unsupervised. Clinical implication: Although diagnosis of EOT2D can be an impetus for behaviour change, diabetes management in this cohort was not prioritised over work and family commitments. Diabetes management and education in this young cohort needs to have tailored approaches. Disclosure: Y. Gu: None. A. Harmer: None. J. Wong: Advisory Panel; Self; Sanofi. Speaker’s Bureau; Self; AstraZeneca, Merck & Co., Inc. A. Gauld: None. M.I. Constantino: None. P.A. Munoz: None. S. Dennis: None. Funding: Diabetes Australia; Sydney Local Health District
- 1 June 2020
- Published by American Diabetes Association in Diabetes
- Vol. 69 (Supplement)
1236-P: Perceptions of People with Early-Onset Type 2 Diabetes Mellitus about Diabetes and Exercise
Background: The prevalence of early-onset type 2 diabetes (EOT2D, diagnosed with T2DM under the age 40) is increasing. There is limited research on the perceptions and knowledge about diabetes and its management. The aim of the study was to explore the insights on diabetes and exercise among this cohort. Method: Twelve participants who underwent an 8-week, supervised, high-intensity intermittent training (HIIT) program were invited to participate in a semi-structured interview. The interview explored exercise history, perception of EOT2D, knowledge of EOT2D management and complications, feedback on HIIT, and barriers and facilitators to regular exercise. Inductive thematic analysis was used. Results: Eight males and four females aged between 20-44 years were interviewed. Four themes emerged from analysis: (i) The diagnosis of T2DM was often unexpected. Participants reported the sense of “loss control” at diagnosis. This motivated people to exercise, but regular and structured exercise was rarely maintained: “didn’t continue after a few months.” (ii) Participants had varying levels of knowledge about diabetes, its management and complications: “⋯didn’t really understand how T2DM works and how exercise could affect it.” Most participants did not monitor blood glucose levels regularly: “monitoring sugar regularly to me is obsessive behaviour.” (iii) Financial and time commitments were the two most common barriers to exercise, especially for people with young children. (iv) HIIT was well-tolerated. Participants valued the individual supervision - “having the supervision gives you structure and a commitment.” However, participants were unlikely to continue with the HIIT program independently or unsupervised. Clinical implication: Although diagnosis of EOT2D can be an impetus for behaviour change, diabetes management in this cohort was not prioritised over work and family commitments. Diabetes management and education in this young cohort needs to have tailored approaches. Disclosure: Y. Gu: None. A. Harmer: None. J. Wong: Advisory Panel; Self; Sanofi. Speaker’s Bureau; Self; AstraZeneca, Merck & Co., Inc. A. Gauld: None. M.I. Constantino: None. P.A. Munoz: None. S. Dennis: None. Funding: Diabetes Australia; Sydney Local Health District
- 1 June 2020
- Published by American Diabetes Association in Diabetes
- Vol. 69 (Supplement)
559-P: Signs of Early Change in Peripheral Axons in People with Early-Onset Type 2 Diabetes Mellitus
Introduction: The prevalence of early-onset type 2 diabetes (EOT2D; diagnosed with T2DM before 40 years old), has increased sharply in recent years. Peripheral neuropathy (DPN) is a common and debilitating complication associated with T2DM, and it is also common in EOT2D, even among adolescents. Nerve excitability studies (NES) examine nerve axonal ion channel function; and may allow early detection of axonal dysfunction. The aim of this study was to explore the differences in NES outcomes between a cohort with EOT2D and matched healthy controls. Method: Thirteen participants with EOT2D with no clinical evidence of DPN and 14 matched healthy control participants (HC) were included in the study. Nerve conduction studies (NCS) were used to assess amplitude, latency, and conduction velocity in sural (sensory) and peroneal (motor) nerves. Motor and sensory NES were conducted on the median nerve. NES parameters assessed included strength-duration time constant, threshold electrotonus (TE), current-threshold relationship and recovery cycle. HbA1c was measured. Independent sample t-tests were used to compare the group means ± standard deviations. Results: Participants with EOT2D (F:M 5:8, age 34.1±6.7yr, BMI 31.7±5.4kg∙m-2) differed from matched HC (F:M 6:8, age 32.5±5.1yr, BMI 29.6±4.4kg∙m-2) for HbA1c (EOT2D=6.8±1.0%, HC=5.2±0.3%, p<0.0001). There were no significant between-group differences in any NCS parameters, confirming the absence of clinical neuropathy. Minor changes in sensory axon NES were found in TE, which measures internodal conductances. Sensory depolarizing TE (TEd) at 10-20ms was decreased significantly in the EOT2D group (TEd 10-20ms: EOT2D = 60.1±2.9ms, HC = 62.9±3.0ms, p = 0.02). There were no significant changes in motor NES. Conclusion: Participants with EOT2D and no clinical evidence of DPN may demonstrate minor changes in sensory axonal function. Prospective studies are required to determine the clinical significance and progression of these changes. Disclosure Y. Gu: None. A.R. Harmer: None. S.M. Dennis: None. T. Li: None. H.C. Timmins: None. P. Loh: None. N. Garg: None. T. Dharmadasa: None. J. Wong: Advisory Panel; Self; Sanofi. Speaker’s Bureau; Self; AstraZeneca, Merck & Co., Inc. A. Gauld: None. P.A. Munoz: None. S.B. Park: None. Funding Diabetes Australia; Sydney Local Health District
- 1 June 2020
- Published by American Diabetes Association in Diabetes
- Vol. 69 (Supplement)
559-P: Signs of Early Change in Peripheral Axons in People with Early-Onset Type 2 Diabetes Mellitus
Introduction: The prevalence of early-onset type 2 diabetes (EOT2D; diagnosed with T2DM before 40 years old), has increased sharply in recent years. Peripheral neuropathy (DPN) is a common and debilitating complication associated with T2DM, and it is also common in EOT2D, even among adolescents. Nerve excitability studies (NES) examine nerve axonal ion channel function; and may allow early detection of axonal dysfunction. The aim of this study was to explore the differences in NES outcomes between a cohort with EOT2D and matched healthy controls. Method: Thirteen participants with EOT2D with no clinical evidence of DPN and 14 matched healthy control participants (HC) were included in the study. Nerve conduction studies (NCS) were used to assess amplitude, latency, and conduction velocity in sural (sensory) and peroneal (motor) nerves. Motor and sensory NES were conducted on the median nerve. NES parameters assessed included strength-duration time constant, threshold electrotonus (TE), current-threshold relationship and recovery cycle. HbA1c was measured. Independent sample t-tests were used to compare the group means ± standard deviations. Results: Participants with EOT2D (F:M 5:8, age 34.1±6.7yr, BMI 31.7±5.4kg∙m-2) differed from matched HC (F:M 6:8, age 32.5±5.1yr, BMI 29.6±4.4kg∙m-2) for HbA1c (EOT2D=6.8±1.0%, HC=5.2±0.3%, p<0.0001). There were no significant between-group differences in any NCS parameters, confirming the absence of clinical neuropathy. Minor changes in sensory axon NES were found in TE, which measures internodal conductances. Sensory depolarizing TE (TEd) at 10-20ms was decreased significantly in the EOT2D group (TEd 10-20ms: EOT2D = 60.1±2.9ms, HC = 62.9±3.0ms, p = 0.02). There were no significant changes in motor NES. Conclusion: Participants with EOT2D and no clinical evidence of DPN may demonstrate minor changes in sensory axonal function. Prospective studies are required to determine the clinical significance and progression of these changes. Disclosure Y. Gu: None. A.R. Harmer: None. S.M. Dennis: None. T. Li: None. H.C. Timmins: None. P. Loh: None. N. Garg: None. T. Dharmadasa: None. J. Wong: Advisory Panel; Self; Sanofi. Speaker’s Bureau; Self; AstraZeneca, Merck & Co., Inc. A. Gauld: None. P.A. Munoz: None. S.B. Park: None. Funding Diabetes Australia; Sydney Local Health District
- Open Access
- 1 January 2019
- Published by United Scientific Group in Journal of Obesity and Chronic Diseases
- Vol. 03 (02)
Proceedings of the Fifth International Conference on Obesity and Chronic Diseases (ICOCD-2019)
Low carbohydrate diets are a matter of controversy for more than hundred years. From time to time this kind of diets are highly popular.
- 1 January 2019
- Published by United Scientific Group in Journal of Obesity and Chronic Diseases
- Vol. 03 (02)
Open AccessProceedings of the Fifth International Conference on Obesity and Chronic Diseases (ICOCD-2019)
Low carbohydrate diets are a matter of controversy for more than hundred years. From time to time this kind of diets are highly popular.